Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for SKVI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.0022M
March 31, 2026 -0.0008M
December 31, 2025 0.002M
September 30, 2025 0.0005M
June 30, 2025 -0.0092M
March 31, 2025 -0.0317M
December 31, 2024 -0.0129M
September 30, 2024 -0.0165M
June 30, 2024 -0.0281M
March 31, 2024 -0.0123M
December 31, 2023 -0.0038M
September 30, 2023 -0.0048M
June 30, 2023 -0.0168M
March 31, 2023 -0.0517M
December 31, 2022 -0.0455M
September 30, 2022 -0.0329M
June 30, 2022 0.1645M
March 31, 2022 -0.0409M
December 31, 2021 0.1538M
September 30, 2021 -0.1174M
June 30, 2021 0.3538M
March 31, 2021 -0.0157M
December 31, 2020 0.0302M
September 30, 2020 -0.0209M
June 30, 2020 0.0523M
Date Value
March 31, 2020 -0.0158M
December 31, 2019 -0.0727M
September 30, 2019 -0.0061M
June 30, 2019 -0.0035M
March 31, 2019 -0.046M
December 31, 2018 -0.0442M
September 30, 2018 0.0158M
June 30, 2018 -0.0305M
March 31, 2018 0.0246M
December 31, 2017 0.1145M
September 30, 2017 -0.0001M
June 30, 2017 -0.1009M
March 31, 2017 -0.0273M
December 31, 2016 -0.1088M
September 30, 2016 -0.0434M
June 30, 2016 -0.0147M
March 31, 2016 -0.0775M
December 31, 2015 -0.2404M
September 30, 2015 -0.1151M
June 30, 2015 -0.188M
March 31, 2015 -0.3093M
December 31, 2014 -0.347M
September 30, 2014 -0.4147M
June 30, 2014 -0.2268M
March 31, 2014 -0.1793M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 1.697M
Integrated BioPharma, Inc. 0.517M
BioForce Nanosciences Holdings, Inc. -0.027M
Nevis Brands, Inc. 0.0481M
Skinhealth Systems, Inc. 2.671M